Abstract:Background: Liver hepatocellular carcinoma (LIHC) is a prevalent malignancy globally, exhibiting substantial incidence and mortality rates. Early diagnosis and prevention of metastasis are crucial for the benefit of patients with liver cancer. The present study aimed to elucidate the involvement of IQCB1 in liver cancer through the utilization of bioinformatics. Methods: The samples utilized in this study were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Initially, the TCGA-LIHC dataset was employed to examine the expression of IQCB1, and its validation was performed on the GSE25097 dataset. Subsequently, Kaplan-Meier (KM) analysis was conducted to evaluate the prognostic significance of IQCB1 in LIHC, and its correlation with clinical pathological features was also investigated. Furthermore, a protein-protein interaction (PPI) network consisting of 20 proteins associated with IQCB1 was constructed using data from the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database, and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were carried out. A risk model was formulated to assess the prognostic significance and its prognostic value was compared to that of IQCB1 in isolation. Furthermore, an examination was conducted to explore the correlation between IQCB1 and immune infiltration, along with the involvement of immunological checkpoints. A drug sensitivity assessment of IQCB1 was performed using the Genomics of Drug Sensitivity in Cancer (GDSC) database. Additionally, the Tumor Immune Single-cell Hub (TISCH) database was utilized to investigate the association between IQCB1 and the tumor microenvironment (TME). Results: The expression of IQCB1 was observed to be significantly elevated in tumor samples. Furthermore, patients with high expression levels of IQCB1 demonstrated a poorer prognosis. Additionally, IQCB1 exhibited significant correlations with MKI67, hepatitis B virus (HBV), hepatitis C virus (HCV), and alpha-fetoprotein (AFP). GO and KEGG analyses revealed enrichment of multiple signaling pathways. Subsequently, an investigation was conducted to examine the association between IQCB1 and the activity of ten signaling pathways related to tumor development. A positive correlation was observed between IQCB1 expression and T-helper 2 (Th2) cells, whereas a negative correlation was observed between IQCB1 expression and Th17 cells. Furthermore, a positive association was found between IQCB1 and immune checkpoints, particularly with CD276. Analysis of single-cell data from the TISCH database revealed widespread expression of IQCB1 in the TME. Additionally, screening revealed that among 12 drugs related to IQCB1, a subset of 10 drugs demonstrated negative correlations, whereas two drugs exhibited positive correlations. Conclusions: IQCB1 has the potential to function as a diagnostic and prognostic molecular marker, and its association with immune infiltration and checkpoint mechanisms has been observed.

Preliminary Research on the Interaction Between SSX2IP and 14-3-3Η

Interaction of 14-3-3σ with KCMF1 Suppresses the Proliferation and Colony Formation of Human Colon Cancer Stem Cells

Research on Screening and Identification of Proteins Interacting with Ataxin-3.

SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma

SSX2IP promotes cell proliferation and migration in breast cancer by regulating FANCI

Quantitative Proteomic Dissection of a Native 14-3-3ε Interacting Protein Complex Associated with Hepatocellular Carcinoma

Screening of Proteins Interacting with p53 by Yeast Two Hybrid System

Landscape of the SOX2 Protein–protein Interactome

Preliminary Study on the Interaction Between Human PIRH2b and ARF4

High expression of disabled homolog 2-interacting protein contributes to tumor development and proliferation in cutaneous squamous cell carcinoma

[14-3-3/HIP-55 Complex Increases the Stability of HIP-55].

Identification of Clinical Value and Biological Effects of XIRP2 Mutation in Hepatocellular Carcinoma

SOX4 Interacts with p53 Protein

[Preliminary structural and functional study on a novel gene HSPCSET].

Prognostic value of SH3PXD2B (Tks4) in human hepatocellular carcinoma: a combined multi-omics and experimental study

The role of IQCB1 in liver cancer: a bioinformatics analysis

Rab3IP Interacts with SSX2 and Enhances the Invasiveness of Gastric Cancer Cells.

Development of Deuterated-leucine Labeling with Immunoprecipitation to Analyze Cellular Protein Complex

A Multidimensional Characterization of E3 Ubiquitin Ligase and Substrate Interaction Network

Kiaa0649, A 1A6/drim-Interacting Protein with the Oncogenic Potential